Skip to main content

Advertisement

Table 1 Clinical characteristics

From: The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn’s disease

  CD UC BD Control P value
Number of patients 39 51 17 16  
Gender      
 Male 20 27 9 14 0.070
 Female 19 24 8 2
Mean age (±SD), yr 32.4 ± 14.5 45.2 ± 22.8 47.5 ± 17.6 32.4 ± 3.8 0.014
BMI (±SD), kg/m2 19.0 ± 3.6 21.6 ± 3.7 20.4 ± 3.8   0.006
CDAI      
  ≥ 150 12     
  < 150 27     
CAI      
  ≥ 6   29    
  < 6   22    
Disease location      
 CD      
  Ileal type 9     
  Ileocolonic type 25     
  Colonic type 4     
  Unknown 1     
 UC      
  Pancolitis   41    
  Left side colon   4    
  Rectum   5    
  Unknown   1    
Current treatment      
  5-ASA 25 43 13   
  Steroid 2 18 6   
  Azathioprine 0 5 0   
  Infliximab 5 0 0   
  Adalimumab 1 0 0   
  GMA/LCAP 1 6 1   
AIM (μg/ml)      
 Average (±SD) 3.3 ± 2.1 1.9 ± 1.4 2.3 ± 1.4 2.1 ± 0.6 <0.001
WBC (±SD), x102/μl 6.7 ± 2.6 8.4 ± 3.9 7.3 ± 2.8 0.055
CRP (±SD), mg/dl 2.5 ± 3.5 3.6 ± 5.8 2.7 ± 4.0 0.929
IgM (±SD), mg/dl 141.5 ± 124.3 118.0 ± 77.9 118.0 ± 64.9 0.275
  1. Abbreviations: GMA/LCAP granulocyte and monocyte adsorptive apheresis / leukocytapheresis, WBC White blood cell, CRP C-reactive protein, IgM Immunoglobulin M